Literature DB >> 12510227

Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease.

I Helmreich-Becker1, P Schirmacher, U Denzer, A Hensel, K H Meyer zum Büschenfelde, A W Lohse.   

Abstract

BACKGROUND AND STUDY AIMS: The diagnosis of cirrhosis has prognostic and therapeutic implications, but early forms are difficult to diagnose. Laparoscopy with histology has been reported to be superior to histology alone, but is often considered to be too invasive. This study aimed to assess whether minilaparoscopy offers similarly high sensitivity coupled with only minor invasiveness. PATIENTS AND METHODS: Minilaparoscopy with biopsy was performed in 226 consecutive patients with chronic liver disease. Cirrhosis was diagnosed macroscopically primarily on the basis of nodularity in a nontumorous liver. A histological diagnosis using the modified Knodell score was made without knowledge of the macroscopic assessment.
RESULTS: Biopsies from 22 patients were inadequate for histological assessment, and 16 of these were considered to be cirrhotic from macroscopic observation. Out of 204 liver biopsies, 94 (46 %) were macroscopically identified as cirrhotic; 68/204 (33 %) showed stage 5 or 6 fibrosis (incomplete or complete cirrhosis). Histological understaging occurred mainly in patients who were otherwise diagnosed as having early Child-Pugh A cirrhosis, macroscopically incomplete cirrhosis and macronodular cirrhosis; 4/204 (2 %) of patients with cirrhosis histologically were understaged macroscopically.
CONCLUSIONS: Macroscopic evaluation during minilaparoscopy increases the sensitivity of detection of liver cirrhosis, compared with biopsy alone, by more than 30 %. Because of its minimal invasiveness, minilaparoscopy combined with biopsy is recommended as a superior method for the staging of chronic liver disease.

Entities:  

Mesh:

Year:  2003        PMID: 12510227     DOI: 10.1055/s-2003-36419

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

Review 1.  Liver elastography, comments on EFSUMB elastography guidelines 2013.

Authors:  Xin-Wu Cui; Mireen Friedrich-Rust; Chiara De Molo; Andre Ignee; Dagmar Schreiber-Dietrich; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

Review 2.  Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base.

Authors:  Kamal K Mahawar; Chetan Parmar; Yitka Graham; Ayman Abouleid; William R J Carr; Neil Jennings; Norbert Schroeder; Peter K Small
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

3.  Mini-laparoscopy in the endoscopy unit: Safety and outcomes in over one thousand patients.

Authors:  Arthur Hoffman; Fareed Rahman; Sarah Prengel; Marcus Schuchmann; Martin Gotz; Markus Moehler; Peter Robert Galle; Ziping Li; Anthony Nicholas Kalloo; Ralf Kiesslich
Journal:  World J Gastrointest Endosc       Date:  2011-01-16

Review 4.  The indications for liver biopsy.

Authors:  Andrea Tannapfel; Hans-Peter Dienes; Ansgar W Lohse
Journal:  Dtsch Arztebl Int       Date:  2012-07-09       Impact factor: 5.594

Review 5.  [Autoimmune liver diseases].

Authors:  S Lüth; C Weiler-Normann; C Schramm; A W Lohse
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

6.  Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience.

Authors:  Olympia E Anastasiou; Matthias Büchter; Hideo A Baba; Johannes Korth; Ali Canbay; Guido Gerken; Alisan Kahraman
Journal:  Hepat Mon       Date:  2016-10-31       Impact factor: 0.660

7.  Gasless balloon laparoscopy.

Authors:  Michael Volland; Mark Lienert; Olaf Horstmann
Journal:  Surg Endosc       Date:  2009-12-29       Impact factor: 4.584

8.  Utilization of murine laparoscopy for continuous in-vivo assessment of the liver in multiple disease models.

Authors:  Yami Shapira; Meirav Katz; Muhammad Ali; Michael Kaplan; Eli Brazowski; Zamir Halpern; Eran Elinav
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.